Skip to main content

Table 1 Overview of the 8 esophageal cancer patients having undergone SN biopsy

From: Sentinel node biopsy during thoracolaparoscopic esophagectomy for advanced esophageal cancer

Patient

Age

Sex

cTNM

Scint.

1 hr

Scint.

3 hrs

Intra-op.

Scint.

Spec.

# hot SN

ex vivo

# dissected

ln

# ln metastases

# SN

tumor pos

Histol.

pTNM

1

69

F

cT1smN0M0

1

5

0

–

4

29

0

0

SCC

T1N0M0

2

57

M

cT3N0M0

2

2

0

1

1

29

10

0

AC

T3N1M1a

3

69

M

cT3N0M0

4

4

0

5

3

39

4

0

AC

T3N0M1a

4

63

M

cT1mN0M0

3

3

2

5

1

35

2

0

SCC

T1N1M0

5

45

M

cT3N0M0

2

2

1

2

3

23

4

0

AC

T3N1M1a

6

60

M

cT3N0M0

2

4

2

5

3

33

5

0

SCC

T3N1M1a

7

71

M

cT2N0M0

0

3

0

4

1

30

0

0

AC

T1N0M0

8

54

M

cT1N0M0

4

7

0

5

5

14

0

0

SCC

T1N0M0

Median

62

–

–

2

3.5

0

5

3

30

3

0

–

–

  1. Legend
  2. AC adenocarcinoma, cTNM clinical tumor node metastasis stage, F female, Histol histology, Hr(s) hour(s), intra-op number of intra-operatively identified structures with focal radioactivity by gamma probe, Ln lymph node, M male, Pos positive, pTNM pathologic tumor node metastasis stage, SCC squamous cell carcinoma, Scint scintigraphy, Scint 1 hr number of focal areas of radioactivity as identified by scintigraphic examination performed 1 h after injection, Scint 3 hrs number of focal areas of radioactivity as identified by scintigraphic examination performed 3 h after injection, Scint specimen number of focal areas of radioactivity as identified by scintigraphic examination of the resected specimen, # hot SN ex vivo number of hot sentinel nodes identified by gamma probe examination of the resected specimen, SN sentinel node